Healthpeak Properties, Inc. (NYSE:DOC) Shares Sold by Bamco Inc. NY

Bamco Inc. NY decreased its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 53.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 138,220 shares of the real estate investment trust's stock after selling 161,359 shares during the quarter. Bamco Inc. NY's holdings in Healthpeak Properties were worth $2,802,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Benjamin Edwards Inc. increased its holdings in Healthpeak Properties by 23.1% during the fourth quarter. Benjamin Edwards Inc. now owns 32,700 shares of the real estate investment trust's stock valued at $663,000 after buying an additional 6,141 shares during the last quarter. BNP Paribas Financial Markets bought a new position in shares of Healthpeak Properties during the 4th quarter valued at approximately $29,580,000. Ameriprise Financial Inc. raised its stake in Healthpeak Properties by 15.6% during the 4th quarter. Ameriprise Financial Inc. now owns 6,671,491 shares of the real estate investment trust's stock worth $134,028,000 after acquiring an additional 902,171 shares during the period. Algert Global LLC purchased a new position in Healthpeak Properties during the fourth quarter valued at approximately $4,289,000. Finally, Alyeska Investment Group L.P. boosted its position in shares of Healthpeak Properties by 160.5% in the fourth quarter. Alyeska Investment Group L.P. now owns 2,591,773 shares of the real estate investment trust's stock worth $52,535,000 after purchasing an additional 1,596,740 shares during the period. 93.57% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director John T. Thomas purchased 4,200 shares of Healthpeak Properties stock in a transaction that occurred on Monday, April 28th. The stock was purchased at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the transaction, the director now directly owns 813,566 shares in the company, valued at approximately $14,514,017.44. This trade represents a 0.52 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Scott M. Brinker purchased 11,337 shares of the stock in a transaction that occurred on Monday, April 28th. The shares were acquired at an average price of $17.68 per share, for a total transaction of $200,438.16. Following the completion of the transaction, the chief executive officer now directly owns 201,863 shares of the company's stock, valued at $3,568,937.84. The trade was a 5.95 % increase in their position. The disclosure for this purchase can be found here. 0.23% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts recently weighed in on DOC shares. Robert W. Baird lowered their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 29th. StockNews.com cut Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Thursday, May 1st. Wedbush cut their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Scotiabank decreased their price target on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a research note on Friday, February 28th. Finally, Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price objective for the company in a research report on Wednesday, January 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $23.42.

Healthpeak Properties Stock Up 0.6 %

NYSE:DOC traded up $0.11 during trading hours on Friday, reaching $17.50. The company's stock had a trading volume of 4,245,778 shares, compared to its average volume of 4,950,215. Healthpeak Properties, Inc. has a 12 month low of $17.21 and a 12 month high of $23.26. The stock has a 50 day moving average price of $19.08 and a two-hundred day moving average price of $20.26. The company has a market capitalization of $12.16 billion, a P/E ratio of 50.00, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.46. The business had revenue of $702.89 million for the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The business's quarterly revenue was up 15.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.45 earnings per share. Equities analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently announced a dividend, which was paid on Wednesday, April 30th. Investors of record on Friday, April 18th were issued a dividend of $0.1017 per share. The ex-dividend date of this dividend was Thursday, April 17th. This represents a dividend yield of 6.5%. Healthpeak Properties's dividend payout ratio (DPR) is presently 305.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.